Akso Health Group logo AHG - Akso Health Group

Price: -- --
Annual Quarterly
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue
Revenue 14.8 2.4 13.2 6 1.8 6.9 3.7 107.3 22.9 11.9 4.6
Cost of Revenue 15.1 2.3 11.9 5.4 0.5 0 0 8.5 5.1 2.4 1.6
Gross Profit (0.3) 0.1 1.3 0.6 1.2 6.9 3.7 98.8 17.8 9.5 3.0
Operating Expenses
R&D Expenses 0 0 0 0.4 0.4 1.0 0 8.5 5.1 2.4 1.6
SG&A Expenses 3.6 8.8 15.5 3.1 2.1 22.3 10.9 22.9 7.9 5.4 3.3
Other Expenses 162.4 0 0 0.4 25.8 31.7 0 (8.5) (5.1) (2.4) (1.6)
Operating Expenses 166.0 8.8 15.5 3.9 28.4 55.0 10.9 22.9 7.9 5.4 3.3
Operating Income
Operating Income (166.3) (8.6) (14.3) (3.3) (27.1) (48.1) (7.2) 75.9 9.9 4.1 (0.3)
Interest Expense 0 0 0 0.8 2.2 2.5 0 0 0 0 0
Interest Income 0 0 0 0 0 0 0 0.6 0 0 0
Profitability
EBITDA (1.8) (8.6) (14.3) (3.2) (28.9) (44.3) (6.8) 76.7 10.0 4.2 (0.3)
EBIT (3.9) (8.6) (14.3) (3.2) (28.9) (44.4) (6.8) 76.5 9.9 4.1 (0.3)
Income Before Tax (166.3) (9.1) (13.1) (4.0) (3.8) (46.9) (6.8) 76.5 10.1 4.2 (0.3)
Income Tax Expense (30.8) 0.0 0.0 0.1 0.5 0.5 0.8 11.0 1.5 0.6 0.0
Net Income (135.0) (9.5) (1.4) (16.8) (34.8) (71.2) 5.5 65.5 8.6 3.5 (0.4)
Per Share Data
EPS (Basic) -0.48 -0.45 -0.06 -2.55 -0.26 -13.14 0.93 12.36 1.62 0.66 -0.07
EPS (Diluted) -0.48 -0.39 -0.06 -2.55 -0.27 -13.14 0.93 12.36 1.62 0.66 -0.07
Shares Outstanding 285.1 20.8 7.6 6.6 5.4 5.4 5.9 5.3 5.3 5.3 5.3
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Current Assets
Cash & Cash Equivalents 176.2 85.2 7.9 18.4 15.1 6.7 57.4 132.6 19.2 7.8 1.0
Short-Term Investments 0 0 0 0 0 0 0 0 0 0 0
Net Receivables 12.9 0 9.2 20 14.4 36.3 37.0 29.3 2.2 1.2 0
Inventory 0.2 0.2 1.7 7.8 0 0 0 0 0 0 0
Other Current Assets 6.8 0.4 1.6 16.2 0 8.7 0 0 6.1 0 0.9
Total Current Assets 196.1 142.0 20.5 62.6 30.1 52.0 97.7 163.1 27.6 9.6 1.8
Non-Current Assets
Property, Plant & Equipment 0.1 0 0 0.1 0.1 0.8 1.3 0.8 0.4 0.3 0.2
Goodwill 10.8 0 0 0 0 0 0 0 0 0 0
Intangible Assets 7.9 0 0 0 0 0 0 0.3 0 0 0
Long-Term Investments 0 0 0 0 0 1.6 30.8 0 0 0 0
Other Non-Current Assets 0 0 0 0.1 1.5 26.1 39.8 (0.3) 0 12.0 5.3
Total Non-Current Assets 18.8 0 0 0.2 1.6 28.5 75.6 0.8 0.8 12.8 5.5
Total Assets 215.0 142.0 20.5 62.8 31.7 80.5 173.3 163.9 28.4 22.4 7.4
Current Liabilities
Account Payables 0 0 0 0 0 0 0 0 0 0 0
Short-Term Debt 0 0 0 0 10 0 0 0 0 0 0
Deferred Revenue 10.2 0.4 0.2 0 0 0.1 0.1 0 0 0 0
Other Current Liabilities 0 0 0.7 13.0 0 8.3 0 0 0 2.7 3.3
Total Current Liabilities 13.8 3.6 11.6 50.5 14.4 12.4 26.6 23.8 4.9 8.4 4.0
Non-Current Liabilities
Long-Term Debt 0 0 0 0 0 20 20 0 0 0 0
Deferred Tax Liabilities 1.9 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0 0 (0.1) 0 0 0 0 0
Total Non-Current Liabilities 2.0 0 0 0 0 20.0 20.2 3,787.0 0 0 0
Total Liabilities 15.8 3.6 11.6 50.5 14.4 32.4 46.8 23.8 4.9 8.4 4.0
Stockholders' Equity
Common Stock 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0
Retained Earnings (198.9) (63.9) (54.5) (53.1) (36.3) (1.4) 69.8 77.2 11.8 3.2 (0.4)
Accumulated Other Comprehensive Income (3.8) (4.1) (3.8) (1.6) (3.1) (7.0) (1.8) 4.4 (1.5) (0.5) 0.0
Total Stockholders' Equity 199.1 138.4 8.7 12.3 17.3 48.1 126.5 140.0 23.5 14.0 3.4
Total Liabilities & Equity 215.0 142.0 20.5 62.8 31.7 80.5 173.3 163.9 28.4 22.4 7.4
Debt Metrics
Total Debt 0.1 0 0 0 10 20.8 20 0 0 0 0
Net Debt (176.1) (85.2) (7.9) (18.4) (5.1) 14.1 (37.4) (132.6) (19.2) (7.8) (1.0)
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Operating Activities
Net Income (135.5) (9.1) (13.1) (16.8) (34.7) (71.2) 5.5 65.5 8.6 3.5 (0.4)
Depreciation & Amortization 2.1 0 0 0.0 0.0 0.6 0.4 0.2 0.1 0.1 0.0
Stock-Based Compensation 0 0 0 0.4 0.1 0.3 6.6 1.8 0 0 0
Change in Working Capital 3.0 2.1 (1.2) (2.6) 21.1 (30.9) (15.3) 20.3 (0.6) 3.8 3.1
Other Non-Cash Items 162.3 8.4 11.0 10.4 (3.2) (3,539.6) 3,725.2 (0.5) 0.3 (0.2) 0.4
Operating Cash Flow 1.2 1.4 (3.3) (8.6) 10.1 (55.9) (1.7) 87.7 8.2 7.0 2.6
Investing Activities
Capital Expenditure (0.2) 0 0 (0.0) 0 (0.3) (0.9) (0.5) (0.3) (0.1) (0.2)
Acquisitions (93.8) 0 0 0 0 0.0 0.0 0 0 0 0
Purchases of Investments 0 0 0 0 0 (14.6) (16.5) 0 0 0 0
Sales/Maturities of Investments 0 0 0 0 0 (0.0) (0.0) 0 0 0 0
Other Investing Activities (12.0) (54.7) 18.5 (20.0) (0.0) 27.7 (50.7) (27.2) 0 0 0
Investing Cash Flow (105.9) (54.7) 18.5 (20.0) (0.0) 12.8 (68.1) (27.6) (0.3) (0.1) (0.2)
Financing Activities
Net Debt Issuance 0 (7.7) (27.5) (10) (10) 0 20 0 0 0 0
Stock Repurchased 0 0 0 0 0 (2.7) (1.3) 0 0 0 0
Dividends Paid 0 0 0 0 0 0 (19.5) 0 0 0 0
Other Financing Activities 0 0 0 34.8 1.0 (1.3) 0.8 4.2 2.3 0.2 (1.4)
Financing Cash Flow 195.9 131.7 (27.5) 34.8 (9.0) (4.0) (0.0) 47.5 4.3 0.2 (1.4)
Cash Position
Net Change in Cash 90.0 77.0 (12.7) 6.8 4.2 (46.4) (75.3) 113.4 11.4 6.9 1.0
Cash at Beginning 86.2 9.2 21.9 15.1 10.9 57.4 132.6 19.2 7.8 1.0 0
Cash at End 176.2 86.2 9.2 21.9 15.1 10.9 57.4 132.6 19.2 7.8 1.0
Free Cash Flow 1.0 1.4 (3.3) (8.6) 10.1 (56.2) (2.7) 87.3 7.9 6.9 2.4
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Income Statement
Revenue 14.8 2.4 13.2 6 1.8 6.9 3.7 107.3 22.9 11.9 4.6
Gross Profit (0.3) 0.1 1.3 0.6 1.2 6.9 3.7 98.8 17.8 9.5 3.0
Operating Income (166.3) (8.6) (14.3) (3.3) (27.1) (48.1) (7.2) 75.9 9.9 4.1 (0.3)
Net Income (135.0) (9.5) (1.4) (16.8) (34.8) (71.2) 5.5 65.5 8.6 3.5 (0.4)
EPS (Diluted) -0.48 -0.39 -0.06 -2.55 -0.27 -13.14 0.93 12.36 1.62 0.66 -0.07
Balance Sheet
Cash & Equivalents 176.2 85.2 7.9 18.4 15.1 6.7 57.4 132.6 19.2 7.8 1.0
Total Assets 215.0 142.0 20.5 62.8 31.7 80.5 173.3 163.9 28.4 22.4 7.4
Total Debt 0.1 0 0 0 10 20.8 20 0 0 0 0
Stockholders' Equity 199.1 138.4 8.7 12.3 17.3 48.1 126.5 140.0 23.5 14.0 3.4
Cash Flow
Operating Cash Flow 1.2 1.4 (3.3) (8.6) 10.1 (55.9) (1.7) 87.7 8.2 7.0 2.6
Capital Expenditure (0.2) 0 0 (0.0) 0 (0.3) (0.9) (0.5) (0.3) (0.1) (0.2)
Free Cash Flow 1.0 1.4 (3.3) (8.6) 10.1 (56.2) (2.7) 87.3 7.9 6.9 2.4